Published ahead of print on March 30, 2006, doi:10.1164/rccm.200509-1461OC
American Journal of Respiratory and Critical Care Medicine Vol 174. pp. 31-40, (2006)
© 2006 American Thoracic Society
doi: 10.1164/rccm.200509-1461OC
Impaired Alveolar Macrophage Response to Haemophilus Antigens in Chronic Obstructive Lung Disease
Charles S. Berenson,
Catherine T. Wrona,
Lori J. Grove,
Jane Maloney,
Mary Alice Garlipp,
Paul K. Wallace,
Carleton C. Stewart and
Sanjay Sethi
Infectious Disease Division, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo School of Medicine; and Laboratory of Flow Cytometry, Roswell Park Cancer Institute, Buffalo, New York
Correspondence and requests for reprints should be addressed to Charles S. Berenson, Division of Infectious Diseases (151), VA Western NY Healthcare System, 3495 Bailey Avenue, Buffalo, NY 14215. E-mail: berenson{at}acsu.buffalo.edu
Rationale: Interactions of nontypeable Haemophilus influenzae (NTHI) with macrophages are implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD). However, the immunologic mechanisms that mediate NTHI-macrophage inflammation are poorly understood. Outer membrane protein (OMP) P6 and lipooligosaccharide (LOS) of NTHI are potent immunomodulators. We theorized that alveolar macrophages in COPD possess fundamental immune defects that permit NTHI to evade host responses.
Objective: To test this hypothesis, we obtained human alveolar and blood macrophages from exsmokers with COPD, exsmokers without COPD, and nonsmokers.
Methods: Alveolar and blood macrophages from each donor were incubated with purified LOS and OMP P6 and with OMP P2 and the total outer membrane preparation (0.11 µg/ml).
Measurements: Supernatants (24 h) were assayed for IL-1 , TNF- , IL-10, IL-12, and IL-8 by multianalyte multiplexed flow cytometry.
Results: Comparative induction of COPD and non-COPD alveolar macrophages by LOS and OMP P6 revealed diminished IL-8, TNF- , and IL-1 responses of COPD alveolar macrophages (p 0.03 for each). COPD alveolar macrophages also had diminished responses to total outer membrane (p 0.03 for each). In contrast, COPD blood macrophages had no significant differences among donor groups in IL-8, TNF- , or IL-1 responsiveness to NTHI antigens. Diminished IL-12 responses of COPD blood macrophages to NTHI antigens, compared with nonsmokers, could not be independently dissociated from group differences in age and pack-years.
Conclusions: These findings support a paradigm of defective immune responsiveness of alveolar macrophages, but not blood macrophages, in COPD.
Key Words: chronic obstructive pulmonary disease macrophage, alveolar nontypeable Haemophilus influenzae phagocytosis
This article has been cited by other articles:

|
 |

|
 |
 
S. Sethi, P. Mallia, and S. L. Johnston
New Paradigms in the Pathogenesis of Chronic Obstructive Pulmonary Disease II
Proceedings of the ATS,
September 15, 2009;
6(6):
532 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Gaschler, M. Skrtic, C. C. J. Zavitz, M. Lindahl, P.-O. Onnervik, T. F. Murphy, S. Sethi, and M. R. Stampfli
Bacteria Challenge in Smoke-exposed Mice Exacerbates Inflammation and Skews the Inflammatory Profile
Am. J. Respir. Crit. Care Med.,
April 15, 2009;
179(8):
666 - 675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi and T. F. Murphy
Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med.,
November 27, 2008;
359(22):
2355 - 2365.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Pasqua, G. Biscione, G. Crigna, and M. Cazzola
Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers
Therapeutic Advances in Respiratory Disease,
August 1, 2008;
2(4):
209 - 214.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Gaschler, C. C. J. Zavitz, C. M. T. Bauer, M. Skrtic, M. Lindahl, C. S. Robbins, B. Chen, and M. R. Stampfli
Cigarette Smoke Exposure Attenuates Cytokine Production by Mouse Alveolar Macrophages
Am. J. Respir. Cell Mol. Biol.,
February 1, 2008;
38(2):
218 - 226.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 American Thoracic Society
|
|
|